Transcriptome profiling of both normal and tumor fibroblasts revealed tumor specific targets of Ets2 including genes involved in matrix remodeling and angiogenesis in the context of both PyMT and ErbB2. Consistent with the gene expression results, loss of Ets2 in tumor fibroblasts decreased tumor associated blood vessels in both models. This evidence concerns the gene ETS2 and neoplasm.